LG100754

Item number	Size	Manual	Delivery time	Price
TGM-T15748-25mg	25 mg	-	7 - 10 business days*	973.00€
TGM-T15748-50mg	50 mg	-	7 - 10 business days*	1,265.00€
TGM-T15748-100mg	100 mg	-	7 - 10 business days*	1,933.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: LG100754 (UVI 2112) is an insulin sensitizer that functions through RXR. LG100754 is... more

Close menu

Product information "LG100754"

Description: LG100754 (UVI 2112) is an insulin sensitizer that functions through RXR. LG100754 is an RXR dimer modulator. LG100754 acts as an RXR: RXR homodimer antagonist, but functions as an agonist towards RXR: PPARalpha and RXR: PPARgamma heterodimers. Target: PPAR. Smiles: CCCOc1cc2c(cc1\C(C)=C/C=C/C(/C)=C/C(O)=O)C(C)(C)CCC2(C)C. References: Cesario RM, et al. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol Endocrinol. 2001 Aug,15(8):1360-9.

Keywords:	UVI 2112
Supplier:	TargetMol
Supplier-Nr:	T15748

Properties

Application:	RXR homodimer antagonist, RXR:PPAR alpha/gamma heterodimer agonist
MW:	396.56 D
Formula:	C26H36O3

Database Information

CAS :	180713-37-5\| Matching products
KEGG ID :	K07294 \| Matching products

Handling & Safety

Storage:	+4°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "LG100754"

Write a review